This week is marking one year from the official launch of the SOPHiA DDM TM Homologous Recombination Deficiency (HRD) Solution, accelerating and empowering our customers’ clinical cancer research decisions with cost-effective, accurate and fast in-house results. The post Celebrating 1 Year of SOPHiA DDM™ Homologous Recombination Deficiency (HRD) Solution! appeared first on SOPHiA GENETICS .